ETF MANAGERS GROUP, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$3,075,139
-18.0%
51,133
+3.6%
0.10%
-17.5%
Q3 2022$3,751,000
+13.5%
49,367
+8.2%
0.12%
+25.0%
Q2 2022$3,305,000
-35.2%
45,643
-24.8%
0.10%
-5.9%
Q1 2022$5,103,000
-2.3%
60,695
-7.3%
0.10%
-1.0%
Q4 2021$5,225,000
-34.7%
65,455
-5.0%
0.10%
-31.3%
Q3 2021$8,004,000
-51.5%
68,898
-6.4%
0.15%
-44.2%
Q2 2021$16,487,000
+58.0%
73,646
-11.6%
0.27%
+45.4%
Q1 2021$10,432,000
-12.4%
83,292
+21.7%
0.18%
-29.1%
Q4 2020$11,914,000
+10.9%
68,417
-30.6%
0.26%
-23.5%
Q3 2020$10,746,000
+104.8%
98,589
+8.4%
0.34%
+83.3%
Q2 2020$5,246,000
-10.6%
90,921
+8.5%
0.19%
-31.6%
Q1 2020$5,870,000
-9.8%
83,803
+9.8%
0.27%
+20.4%
Q4 2019$6,510,000
+29.7%
76,355
+11.7%
0.23%
+24.9%
Q3 2019$5,020,000
+34.9%
68,350
+11.8%
0.18%
+53.4%
Q2 2019$3,721,000
+51.8%
61,150
+20.1%
0.12%
-1.7%
Q1 2019$2,452,000
+31.3%
50,912
-8.7%
0.12%
+36.4%
Q4 2018$1,868,000
-31.9%
55,787
+6.5%
0.09%
-14.6%
Q3 2018$2,744,000
+228.6%
52,367
+27.6%
0.10%
+102.0%
Q1 2018$835,000
+20.0%
41,049
+19.7%
0.05%
+2.0%
Q4 2017$696,000
+38.4%
34,289
+35.2%
0.05%
+16.3%
Q3 2017$503,000
+23.3%
25,360
+7.4%
0.04%
+26.5%
Q2 2017$408,00023,6050.03%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders